Skip to content

The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot Drop

The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot Drop

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01001390
Enrollment
2
Registered
2009-10-26
Start date
2009-10-31
Completion date
2011-06-30
Last updated
2014-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lymphoblastic Leukemia, Foot Drop

Keywords

Acute Lymphoblastic leukemia

Brief summary

This study is designed to see if children with acute lymphoblastic leukemia who have developed foot drop during treatment for their leukemia consume less oxygen when walking with or without an ankle brace designed to support their foot during walking. In this study children with foot drop are asked to walk for six minutes with and without brace on their ankle. During each walk, the amount of oxygen used is measured. The child wears a face mask which is attached to a device that records how much oxygen they use. The amount of oxygen used during the walk with the brace on will be compared to the amount of oxygen used with the brace off.

Detailed description

1. This study will determine the impact of Ankle Foot Orthoses (AFO) wear on gait efficiency in children with ALL and Chemotherapy-Induced Peripheral Neuropathy (CIPN). 2. The study hypothesizes that children with CIPN will have lower net oxygen consumption during the six minute walk test while wearing AFO as compared to their net oxygen consumption during a six minute walk test while not wearing AFO. 3. The study will assess whether gait efficiency while using an AFO persists after one month of use. 4. The study will hypothesize that the benefits of AFO use on gait efficiency persist after one month of wear.

Interventions

DEVICEAFO Device

Ankle Foot Orthoses impact on net oxygen consumption.

Sponsors

St. Jude Children's Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Research participant is diagnosed with childhood ALL and currently being treated on the TOTAL XVI protocol at St. Jude Children's Research Hospital (SJCRH) 2. Research participant is from 6 to 18 years of age at the time of the scheduled evaluation 3. Research participant has chemotherapy-induced peripheral neuropathy resulting in foot drop 4. Research participant will be receiving AFO 5. Research participant has a hemoglobin level greater than 8 g/dL and a platelet count above 50 x 109/L

Exclusion criteria

1. Participant has Down Syndrome or other known congenital developmental delays 2. Participant has a platelet count lower than 50 x 109/L and a hemoglobin level less than 8 g/dL 3. Participant has a lower extremity amputation, congenital deformity of the lower limb or an acute fracture of the lower limb 4. Participant has symptomatic osteonecrosis in the lower extremities

Design outcomes

Primary

MeasureTime frameDescription
Net Oxygen Consumption During the Six Minute Walk Test Among Study Participants Under the Two Walking Conditions, With and Without AFO.BaselineNet oxygen consumption is calculated by the formula: \[net oxygen consumption = walking oxygen consumption - sitting oxygen consumption\], then adjusted by total mass in kg, including body mass, the mass of the socks, appropriate shoes, helmet, mouth piece system, and for the with AFO trials, the mass of the brace.

Secondary

MeasureTime frameDescription
Number of Participants With Improvement in Gait Efficiency While Using an AFOOne month after baseline evaluationThe difference of net oxygen consumption between wearing AFO and without wearing AFO (difference = wearing AFO - without wearing AFO) will be compared between the baseline study and one month later by using repeated measures analysis in which the effect of time will be tested controlling for other confounding variables.

Countries

United States

Participant flow

Recruitment details

Two participants were enrolled at St. Jude Children's Research Hospital (SJCRH) between February 2010 and January 2011. The study was terminated due to poor accrual and poor participant compliance.

Pre-assignment details

Participants had a diagnosis of acute lymphoblastic leukemia and had developed foot drop during treatment for their leukemia. Randomization was to one of two reporting groups: (1) With then without AFO, and (2) Without then with AFO.

Participants by arm

ArmCount
Group 1: With Then Without AFO
Group one participants were to complete a six minute walk test with ankle foot orthoses (AFO), and after a rest of fifteen minutes, they were to complete another six minute walk test without AFO, with similar speed to the previous test. The process was to be repeated one month later.
2
Total2

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyFailure to wear AFO device20

Baseline characteristics

CharacteristicGroup 1: With Then Without AFO
Age, Customized
> 18 years
0 participants
Age, Customized
6-18 years
2 participants
Age, Customized
< 6 years
0 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 20 / 0
serious
Total, serious adverse events
0 / 20 / 0

Outcome results

Primary

Net Oxygen Consumption During the Six Minute Walk Test Among Study Participants Under the Two Walking Conditions, With and Without AFO.

Net oxygen consumption is calculated by the formula: \[net oxygen consumption = walking oxygen consumption - sitting oxygen consumption\], then adjusted by total mass in kg, including body mass, the mass of the socks, appropriate shoes, helmet, mouth piece system, and for the with AFO trials, the mass of the brace.

Time frame: Baseline

Population: No data was collected for analysis. Two participants were enrolled, however, neither participant agreed to wear an ankle foot orthoses.

Secondary

Number of Participants With Improvement in Gait Efficiency While Using an AFO

The difference of net oxygen consumption between wearing AFO and without wearing AFO (difference = wearing AFO - without wearing AFO) will be compared between the baseline study and one month later by using repeated measures analysis in which the effect of time will be tested controlling for other confounding variables.

Time frame: One month after baseline evaluation

Population: No data was collected for analysis. Two participants were enrolled, however, neither participant agreed to wear an ankle foot orthoses.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026